BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.

Autor: Picceli, V. F.1, Skare, T. L.2, Nisihara, R. M.3, Nass, F. R.1, Messias-Reason, I. T.1, Utiyama, S. R. R.1,4 shirley@ufpr.br
Zdroj: Lupus. Apr2016, Vol. 25 Issue 4, p412-417. 6p. 3 Charts, 1 Graph.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje